CareDx, Inc. SEC filings CDNA

CareDx, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Dec 1, 2017. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
EFFECT Filing May 23, 2024 —
POSASR Filing Feb 28, 2024 —
CT ORDER Filing Dec 22, 2021 —
UPLOAD Letter from the SEC Sep 1, 2020 —
CORRESP Letter to the SEC Aug 26, 2020 —
UPLOAD Letter from the SEC Aug 5, 2020 —
CT ORDER Filing Jul 16, 2019 —
CT ORDER Filing Feb 4, 2019 —
EFFECT Filing Oct 11, 2018 —
CORRESP Letter to the SEC Oct 10, 2018 —
CT ORDER Filing Oct 10, 2018 —
EFFECT Filing Dec 8, 2017 —
CORRESP Letter to the SEC Dec 6, 2017 —

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
CDNA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Brisbane, CA
SEC filer status
Large accelerated filer
SEC CIK
1217234
Former names
XDx, Inc. (until Nov 15, 2011); EXPRESSION DIAGNOSTICS INC (until Dec 14, 2005)

Other Services-Medical Laboratories companies

All 29 Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.